drugset / Trial / NCT00259779
Comparison Between Symbicort® and Prednisolone in COPD
RandomizedParallel-groupDouble-blindTreatment
Summary
To assess if Symbicort forte Turbuhaler (during two weeks) is as effective as an oral course of prednisolone + Oxis Turbuhaler (during two weeks) for the treatment of an acute exacerbation of Chronic Obstructive Pulmonary Disease (COPD).
Timeline
- Start
- 2005-09
- Primary completion
- —
- Completion
- 2007-07
Outcome
Met primary endpoint
paper Non-inferiority of budesonide/formoterol was proven because the lower limit of FEV1-change (97.5% CI) was above 90% of the efficacy of the alternative treatment. PMID 19228428 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Budesonide | Small molecule | 320 ug | Inhaled |
| Subject | Formoterol | Other / unclassified | 9 ug | Inhaled |
| Subject | Prednisolone | Other / unclassified | 30 mg | Oral |